Oak, Maple, Walnut, Ash, Poplar, Dogwood, Or Persimmon Patents (Class 424/771)
  • Patent number: 10391105
    Abstract: The disclosure provides a method of treating a patient having postpartum depression, premenstrual dysphoric disorder, menopausal depression, or delirium tremens comprising administering an effective amount of an injectable neurosteroid formulation to the patient. In certain embodiments the injectable neurosteroid formulation is an injectable ganaxolone formulation. Two types of injectable neurosteroid formulations may be used in the disclosed methods. The first such formulation is an injectable formulation containing ganaxolone and sulfobutyl ether ?-cyclodextrin in a 1:1 inclusion complex. The second such formulation is an injectable neurossteroid formulation comprising a neurosteroid, preferably ganaxolone, but which may be a neurosteroid selected from allopregnanolone, ganaxolone, alphaxalone, alphadolone, hydroxydione, minaxolone, pregnanolone, tetrahydrocorticosterone, and combinations of the foregoing; a surface stabilizer selected from hydroxyl ethyl starch, dextran, and povidone; and a surfactant.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: August 27, 2019
    Assignee: MARINUS PHARMACEUTICALS INC.
    Inventors: Christopher Cashman, Jaakko Lappalainen, David A Czekai
  • Patent number: 9488590
    Abstract: The purpose of the present invention is to provide a rapid and widely practicable cosmetic-evaluating method for evaluating the performance of candidate cosmetics in improving wrinkles in the horny cell layer. Provided is a method for evaluating the effectiveness in wrinkle improvement of a candidate cosmetic by immersing a horny-cell-layer sheet having creases and wrinkles in the candidate cosmetic, and verifying the disappearance of the creases and wrinkles after drying, whereby the purpose is achieved.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: November 8, 2016
    Assignee: Shiseido Company, Ltd.
    Inventors: Ichiro Iwai, Yusuke Hara
  • Patent number: 9186366
    Abstract: It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.
    Type: Grant
    Filed: April 15, 2013
    Date of Patent: November 17, 2015
    Assignee: MEGMILK SNOW BRAND CO., LTD.
    Inventors: Ken Kato, Susumu Miura, Leo Tanaka, Hiroshi Ueno, Noriko Ueda, Yuko Haruta, Toshimitsu Yoshioka
  • Publication number: 20150140143
    Abstract: The present document describes a nutriprotective diet comprising a nutriprotective amount of a sugar plant syrup, a sugar plant syrup extract, a sugar plant extract, or combinations thereof The present document also describes a method of eliciting a nutriprotective effect in a subject, which comprises administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document also describes a method of treating a subject with a disorder, by administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document describes a process for the extraction of polyphenolic compounds from maple syrup using adsorbent materials, and the extracts obtained therefrom.
    Type: Application
    Filed: September 10, 2012
    Publication date: May 21, 2015
    Applicant: FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC
    Inventors: Steeves Potvin, Vincent Bédard, François Béland, Geneviéve Béland, Keiko Abe
  • Publication number: 20150110758
    Abstract: A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.
    Type: Application
    Filed: January 5, 2015
    Publication date: April 23, 2015
    Inventor: Omar M. Amin
  • Publication number: 20150093460
    Abstract: It has been discovered that Red Osier Dogwood can be fed to domesticated animals such as livestock as part of a feeding regimen in place of silage. Surprisingly, the Red Osier Dogwood results in increased growth compared to a control fed a regular diet. Experiments have shown that the Red Osier Dogwood is rich in antioxidants such as rutin, gallic acid, ellagic acid, quercetin and tyrosol. Also described herein are methods of preparing extracts from Red Osier Dogwood comprising high levels of these antioxidants, which can be used in the preparation of medicaments for the administration to animals, including humans.
    Type: Application
    Filed: April 22, 2013
    Publication date: April 2, 2015
    Inventor: Robert Scales
  • Publication number: 20140322369
    Abstract: The present invention relates to a composition consisting of ellagitannins rich extracts originated from plant extracts of the Fagaceae family, for use in a method for preventing or treating sleep and anxiety disorders, fatigue as well as for improving mood, reducing tension and raising energy in a subject.
    Type: Application
    Filed: December 21, 2012
    Publication date: October 30, 2014
    Inventors: Victor Ferrari, Frank Schoenlau, Carolina Burki
  • Patent number: 8834944
    Abstract: The present invention provides an ointment comprising aqueous extract of fig leaves, horse chestnut, artichoke leaves and walnut shells, for the treatment of hemorrhoids; a method of manufacturing such an ointment; and the use of fig leaves, artichoke leaves or walnut shells for the manufacture of a medicament for the treatment of hemorrhoids. Preferably, the ointment further comprises lanolin and petroleum jelly (Vaseline). Preferably, the method comprises extracting fig leaves, horse chestnut, artichoke leaves and/or walnut shells using heated water, and admixing thereto lanolin and petroleum jelly (Vaseline) so as to result in the ointment. The ointment preferably further comprises ‘Huile de Cade’.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: September 16, 2014
    Inventors: Feyyaz Kucukay, Mehmet Sait Kucukay
  • Patent number: 8802163
    Abstract: A natural soap is made using a herbal medicine decoction. The natural soap includes herbs including lotus roots, lotus leaves, red ginseng, Hippophae rhamnoides leaves and trunk, persimmon leaves, thuja orientalis, ginger, rosemary, black beans, black sesame, aloe, mulberry leaves, Orostachys japonicus, Angelica gigas, green tea, pine needles, mint, pleuropterus multiflorus, blueberry, and Acorus gramineus. A ripening device ripens the herbs in temperatures of 65 to 95° C. for 3 to 15 days, distilled water or soft water is poured onto the herbs, and the herbs mixed with the water are decocted by a decoction maker.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: August 12, 2014
    Inventor: Eun Joo Ko
  • Publication number: 20140161903
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 12, 2014
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Matthew J. Chapin, Mark Barry Abelson, Keith Jeffrey Lane, Akimitsu Makino
  • Publication number: 20140120190
    Abstract: Methods of preparing an extract of Prickly-ash peel, including pulverizing the peels of Chinese Prickly-ash berries to produce powdered Prickly-ash peel; extracting the powdered Prickly-ash peel using an organic solvent to yield an organic extract solution; and removing the organic solvent under reduced pressure to yield a residue that is an extract of Prickly-ash peel. The resulting Prickly-ash peel extracts include the active anti-aging ingredient gx-50, having the formula which may be dispersed in a liquid or semi-solid physiologically and cosmetically acceptable vehicles or carriers to form topical anti-aging cosmetics.
    Type: Application
    Filed: October 21, 2013
    Publication date: May 1, 2014
    Inventors: Dong-Qing WEI, Yu-Kun MA, Zhong-Dong QIAO
  • Patent number: 8679550
    Abstract: Fortified food and dietary supplement products may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an IC50 of 3.8 ?L/mL. In vivo bioactivities were evaluated in type 2 diabetic Sprague Dawley rats.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: March 25, 2014
    Assignee: Tahitian Noni International, Inc.
    Inventors: Brett Justin West, Claude Jarakae Jensen, Afa Kehaati Palu, Shixin Deng, Jeffery A. Wasden
  • Patent number: 8663719
    Abstract: The present invention relates generally to herbal calf starter compositions for feeding animals, particularly young animals, and methods of making them, and more particularly relates to shelf-stable and cheaper herbal calf starter compositions for overall development of calves to early complete functional maturity and also prevents any infection by acting as immunobooster. The herbal calf starter compositions comprise effective amount of a mixture of herbal extract and/or at least one bioactive fraction from medicinal herbs and one or more additives selected from Energy Source, Protein Source, Carbohydrate source, Chelated/organic Mineral Mixture, Vitamins, Salt, Toxin destroyer and Biocide. The invention also relates to processes for the preparation of such extracts and herbal calf starter compositions.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: March 4, 2014
    Inventor: Prashant Neminath Patil
  • Publication number: 20130337095
    Abstract: An antimicrobial composition is provided, including melaleuca oil, or an isolated fraction or an active agent or equivalent thereof, manuka oil, or an isolated fraction or an active agent or equivalent thereof, and at least one galloyl moiety.
    Type: Application
    Filed: June 18, 2013
    Publication date: December 19, 2013
    Applicant: Waikatolink Limited
    Inventor: Nichola Robyn Harcourt
  • Publication number: 20130302453
    Abstract: Provided herein is a method for disinfection or infection control against a non-enveloped virus using a composition including, as an active ingredient, a persimmon extract containing tannin from an astringent fruit of a plant of the genus Diospyros, such as the plant Diospyros kaki. The non-enveloped virus is a non-enveloped virus belonging to the genus Betanodavirus, Aquavirnavirus, Ranavirus, Enterovirus, Mastadenovirus, Vesivirus, or Rotavirus. In certain embodiments, the persimmon extract is prepared by heating a squeezed juice or an extract from an astringent fruit of a plant of the genus Diospyros, or obtained by treating a squeezed juice or an extract from an astringent fruit of the plant of the genus Diospyros with an alcohol, in order to inactivate an enzyme contained therein. The persimmon extract may also contain at least condensed tannin.
    Type: Application
    Filed: July 11, 2013
    Publication date: November 14, 2013
    Inventors: Tadashi Shimamoto, Yasushi Okinaka, Takemasa Sakaguchi, Toru Tsuji, Yoshiaki Nakai
  • Patent number: 8551543
    Abstract: The present invention relates to novel maple product compositions. In particular, the present invention relates to new compositions comprising maple sap, maple concentrate, maple syrup or diluted maple syrup, and probiotics, prebiotics or combinations thereof. The present invention also discloses methods for the production of maple based products, including functional drinks, comprising a composition comprising maple sap, maple concentrate, maple syrup or dilutated maple syrup, and probiotics, prebiotics or combinations thereof, as a vehicle for the delivery of probiotics and prebiotics to the gastrointestinal tract.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: October 8, 2013
    Assignee: Fédération des Producteurs Acéricoles du Québec
    Inventors: Geneviève Béland, Julie Barbeau, Ismail Fliss
  • Publication number: 20130202570
    Abstract: A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.
    Type: Application
    Filed: September 20, 2012
    Publication date: August 8, 2013
    Inventor: Omar M. Amin
  • Publication number: 20130164395
    Abstract: Disclosed is a pharmaceutical composition for the prophylaxis and therapy of inflammatory diseases, allergic diseases, or asthma, comprising a velvet apple (Diospyros blancoi A. DC.) extract as an active ingredient. Having the inhibitory activity against the nuclear translocation of NF-?B, whose level is rapidly elevated in response to inflammatory stimuli, the velvet apple extract can suppress the production of NO and PGE2, the expression of iNOS and COX-2, and the release of IL-1? and TNF-?, and can significantly down regulate Th2-mediated IL-4 and IL-13 production. In addition, the extract was found to inhibit the activation of eosinophils in bronchoalveolar lavage fluid, and to suppress the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood, as measured by in vivo tests on an ovalbumin-induced asthma mouse model. Therefore, the extract can be used in the method for preventing or treating various inflammatory disorders, allergic diseases, or asthma.
    Type: Application
    Filed: August 30, 2011
    Publication date: June 27, 2013
    Inventors: Kyung Seop Ahn, Ok-Kyoung Kwon, Sei Ryang Oh, Jung Hee Kim, Hyeong Kyu Lee, Mee-Young Lee, Hwa-Young Son, Kyoung-Youl Lee, Soo Yong Kim, Giselle Tomayo-Castillo, Katia Rosales-Ovares, Rodrigo Gamez-Lobo
  • Publication number: 20130136815
    Abstract: An insect-repellent or insecticidal composition comprising an extract or an organic solvent fraction of oak vinegar as an effective ingredient, is provided. The composition comprising extract or organic solvent fraction of oak vinegar as an effective ingredient has superior insect-repellent or insecticidal activities against lasioderma serricorne, which damages tobacco, grains, paper or clothes, reticulitermes speratus kyushuensis Morimoto, which chews the woods from within, or sitophilus oryzae, which has strong tolerance to insecticides, and therefore, can be applied efficaciously as an insect-repellent or insecticidal composition to conserve wooden furniture, an old house, or many organic cultural heritages.
    Type: Application
    Filed: September 10, 2010
    Publication date: May 30, 2013
    Applicant: Republic of Korea (National Research Institute of Cultural Heritage)
    Inventors: Mi Hwa Jung, Jin Young Hong, Chang Wook Jo, Young-Hee Kim, Jung Eun Choi, So Young Jeong, Soon Hyoung Ghang
  • Patent number: 8404225
    Abstract: The invention disclosed relates to the detection of the Emerald Ash Borer (EAB), Agrilus planipennis Fairmaire (Coleoptra: B-prestidae) and in particular to the use of contact sex phenomones therefor. Analysis of the elytral hydrocarbons from male and female emerald ash borer, that were freshly emerged vs. sexually mature (>10 days old) revealed a female-specific compound, 9-methyl-pentacosane (9-Me-C25), only present in sexually mature females. This material was synthesized by the Wittig reaction of 2-decanone with (n-hexadecyl)-triphenylphosphonium bromide followed by catalytic reduction to yield racemic 9-Me C25, which matched the natural compound by GC/MS (retention time and EI-mass spectrum). In field bioassays with freeze-killed sexually mature A. planipennis females, feral males spent significantly more time in contact and attempting copulation with unwashed females than with females that had been washed in n-hexane to remove the cuticular hydrocarbons.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: March 26, 2013
    Assignee: National Research Council of Canada
    Inventors: Peter Silk, Jon Sweeney, Krista Ryall, Barry Lyons
  • Patent number: 8389030
    Abstract: The invention provides compositions and methods for inhibiting nematode damage to plants. The compositions comprise acid extracts or alcohol extracts from juglone-producing members of the Juglandaceae. The methods comprise applying the compositions of the invention to soil contacting roots of nematode-susceptible plants.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: March 5, 2013
    Assignee: Redox Chemicals, Inc.
    Inventor: Darin J. Moon
  • Publication number: 20130022635
    Abstract: The present invention provides a substance which can modulate expression of a Bmal gene effectively and with a wide range of application. Provided is an expression modulator for the Bmal gene comprising, as an active ingredient, one or more selected from the group consisting of hinoki cypress extract, chlorella extract, hop extract, Zanthoxylum extract, juniper oil, lavender oil, eucalyptus oil, olibanum, cypress oil, palmarosa oil, pineneedle oil, rose oil, ylang-ylang oil, elemi oil, petitgrain oil, pepper oil, thyme oil and chamomile oil.
    Type: Application
    Filed: March 30, 2011
    Publication date: January 24, 2013
    Applicant: SHISEIDO COMPANY, LTD.
    Inventors: Yoko Gozu, Shinichiro Haze, Keiko Mori, Kenichi Umishio
  • Publication number: 20130020226
    Abstract: The invention relates to a high-amino-acid, low-lipid and low-carbohydrate parenteral nutrition solution for administration to obese intensive-care patients, and to a three-chamber pouch which comprises the amino acid component, the carbohydrate component and the lipid component of the parenteral nutrition solution separately in three different chambers.
    Type: Application
    Filed: July 20, 2012
    Publication date: January 24, 2013
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Rosa Abele, Ewald Schlotzer
  • Patent number: 8318219
    Abstract: The invention refers to an isolated extract of walnuts of high efficiency and stability over time useful for the manufacture of a medicament for the treatment of viral, fungal and bacterial diseases, which is characterized in that it is obtained from a process comprising: i) collecting unripe walnut fruits as raw material; ii) preparing the raw material for the extraction, iii) freezing the raw material prepared in the previous step; iv) drying; v) extracting in a time lower than 10 minutes; vi) filtration; and vii) final packaging. The invention also refers to its use for manufacturing a medicament for the treatment of bacterial, fungal and viral diseases and to a composition comprising it.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: November 27, 2012
    Assignee: Hartington Business, S.L.
    Inventor: Vakhtang Mtchedlidze
  • Patent number: 8293292
    Abstract: A Fraxinus excelsior seed extract that can be administered for therapeutic treatment of a subject, including a human, by blocking fat synthesis, activating PPAR-alpha, increasing hypoglycemic activity, reducing bodyweight, controlling fasting plasma insulin levels against hyperinsulinemia, and promoting insulin sensitivity and causing a beneficial acute insulinotropic effect. The Fraxinus excelsior seed extract includes, inter alia, an isolated compound (2S,3E,4S)2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-?-D-glucopyranosyl-?-D-glucopyranosyl)oxy]-3,4-dihydro-5-(methoxycarbonyl)methyl ester, commonly called excelside A, an isolated compound (2S,3E,4S) 2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-?-D-glucopyranosyl-?-D-glucopyranosyl)oxy]-3,4-dihydro-5-(methoxycarbonyl)2-(4-hydroxyphenyl)ethyl ester, commonly called excelside B, and the compounds GI5, GI3, nuzhenide, and oleoside dimethyl ester.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: October 23, 2012
    Assignee: Naturex, S.A.
    Inventors: Kan He, Marc Roller, Antoine Bily, Naisheng Bai, Jacques DiKansky, Alvin Ibarra
  • Publication number: 20120263812
    Abstract: The invention relates to the use of at least one plant of the species Punica granatum or an extract thereof as an agent for reducing or preventing the whitening of head hair and/or bodily hair, said extract being used orally. The invention also relates to a cosmetic treatment process by administration of Punica granatum.
    Type: Application
    Filed: October 29, 2010
    Publication date: October 18, 2012
    Applicants: NESTEC SA, L'OREAL
    Inventor: Stephane Commo
  • Publication number: 20120225053
    Abstract: The present invention provides methods for preventing, treating, managing and/or ameliorating a condition associated with inflammation (e.g., an inflammatory disorder) or a symptom thereof, the methods comprising administering to a subject in need thereof an effective amount of a theaflavin composition and an effective amount of one or more therapies other than such a theaflavin composition. In particular, the present invention provides methods for preventing, treating, managing and/or ameliorating a condition associated with inflammation (e.g., an inflammatory disorder) or a symptom thereof, the methods comprising administering to a subject in need thereof an effective amount of a theaflavin composition, an effective amount of a glucosamine composition, and optionally one or more other therapies.
    Type: Application
    Filed: May 24, 2006
    Publication date: September 6, 2012
    Inventors: Slavik Dushenkov, Patricia Lucas-Schnarre, Julie Beth Hirsch, David Evans, Kitty Evans
  • Patent number: 8241635
    Abstract: The present invention relates to silver-ionized plant extraction liquid and the use thereof. Particularly, there are provided herein a silver-ionized liquid extraction liquid prepared by ionizing silver in a plant extraction liquid used as an electrolyte and an antimicrobial composition comprising the same.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: August 14, 2012
    Assignees: Damyangkun
    Inventors: Dong-gyu Bai, Jeong-ho Lee, Kyu-jeong Cho, Sun-mi Huh, Sang-hwa Park
  • Patent number: 8206755
    Abstract: The invention refers to an isolated extract of walnuts of high efficiency and stability over time useful for the manufacture of a medicament for the treatment of viral, fungal and bacterial diseases, which is characterized in that it is obtained from a process comprising: i) Collecting unripe walnut fruits as raw material; ii) Preparing the raw material for the extraction; iii) Freezing the raw material prepared in the previous step; iv) Drying; v) Extracting in a time lower than 10 minutes; vi) Filtration; and vii) Final packaging. The invention also refers to its use for manufacturing a medicament for the treatment of bacterial, fungal and viral diseases and to a composition comprising it.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: June 26, 2012
    Assignee: Hartington Business, S.L.
    Inventor: Vakhtang Mtchedlidze
  • Publication number: 20120100223
    Abstract: Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 26, 2012
    Applicant: ASHA NUTRITION SCIENCES, INC.
    Inventor: Urvashi BHAGAT
  • Patent number: 8142826
    Abstract: A Fraxinus excelsior seed extract that can be administered for therapeutic treatment of a subject, including a human, by blocking fat synthesis, activating PPAR-alpha, increasing hypoglycemic activity, reducing bodyweight, controlling fasting plasma insulin levels against hyperinsulinemia, and promoting insulin sensitivity and causing a beneficial acute insulinotropic effect. The Fraxinus excelsior seed extract includes, inter alia, an isolated compound (2S,3E,4S) 2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-?-D-glucopyranosyl-?-D-glucopyranosyl) oxy]-3,4-dihydro-5-(methoxycarbonyl)methyl ester, commonly called excelside A, an isolated compound (2S,3E,4S) 2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-?-D-glucopyranosyl-?-D-glucopyranosyl)oxy]-3,4-dihydro-5-(methoxycarbonyl) 2-(4-hydroxyphenyl)ethyl ester, commonly called excelside B, and the compounds GI5, GI3, nuzhenide, and oleoside dimethyl ester.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: March 27, 2012
    Assignee: Naturex, Inc.
    Inventors: Kan He, Marc Roller, Antoine Bily, Naisheng Bai, Jacques Dikansky, Alvin Ibarra
  • Publication number: 20120040034
    Abstract: A method for improving water quality in aquatic ecosystems is described. An effective amount of Quercus infectoria nut gall powder is added to the ecosystem to prevent excessive proliferation of pathogenic bacterial species thereby improving the health of aquaculture species in the ecosystem.
    Type: Application
    Filed: February 15, 2011
    Publication date: February 16, 2012
    Applicant: Kemin Industries, Inc.
    Inventors: M. Rajalekshmi, R. Sripathy, Haridasan Chirakkal
  • Publication number: 20120034289
    Abstract: The invention relates to a method for preparing antimicrobial material. The method comprises heating material comprising wood or bark or material derived therefrom, under conditions sufficient to render the material antimicrobial. The invention also relates to antimicrobial materials prepared by such methods, and to various uses of the antimicrobial materials, for example in reducing microbial activity in animal bedding, such as that which is used in poultry farming.
    Type: Application
    Filed: November 12, 2009
    Publication date: February 9, 2012
    Applicants: THE FORESTRY COMMISSION, UNIVERSITY OF SURREY
    Inventors: Franciscus Antonius Anna Maria De Leij, Mina Kalantarzadeh, Tony Hutchings
  • Patent number: 8063026
    Abstract: Provided herein are methods of using mannan oligosaccharides, to treat, palliate, relieve, prevent and/or eliminate urinary tract infections of humans. A mixture of oligosaccharides derived from yeast cell walls is shown to reduce, eliminate and prevent the symptoms of UTI in patients.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: November 22, 2011
    Inventor: Richard Katz
  • Publication number: 20110280969
    Abstract: A substantially non-aqueous, aerated composition is free of petroleum-based components and is suitable for skin applications. The composition primarily includes wax and oil, and can further include vitamin E oil and an essential oil. The composition can be a semi-solid at room temperature. A method of making the composition includes melting together component ingredients to form a mixture, which is then cooled to form hardened matter. The hardened matter is blended to form a flowable mixture, which is then forced through a sieve to form the aerated composition.
    Type: Application
    Filed: March 29, 2011
    Publication date: November 17, 2011
    Applicant: Waxelene, Inc.
    Inventors: Chris Ejyo Remington, Todd Stuart Cooper
  • Publication number: 20110244041
    Abstract: The invention relates to a hydrolyzate from at least one extract of at least one plant material selected from the group consisting of at least one genus: Equiseti, Juglandis, Millefolii, Quercus, Taraxaci, Althaeae, Matricariae, Centaurium, Levisticum, Rosmarinus, Angelica(e), Artemisia, Astragalus, Leonurus, Salvia, Saposhnikovia, Scutellaria, Siegesbeckia, Armoracia, Capsicum, Cistus, Echinacea, Echinacea, Galphimia, Hedera, Melia, Olea, Pelargonium, Phytolacca, Primula, Salix, Thymus, Vitex, and Vitis; and to a mixture thereof and to a method of production and the use thereof. The invention further relates to an agent and drug obtainable on the basis of the hydrolyzate.
    Type: Application
    Filed: November 2, 2009
    Publication date: October 6, 2011
    Applicant: BIONORICA SE
    Inventor: Michael A. Popp
  • Patent number: 8021702
    Abstract: The method of human prophylaxis comprising a number of steps is claim. First, the client is prepared for a steam bath, by applying a herbal paste on the skin, over at least one area of the client's body. The herbal paste is allowed to be absorbed into the client's body for an amount of time of at least five minutes and is followed with a massage the client's body. The client is then placed into a cedar steam barrel, connected to the steam generator, where the client's body is exposed to the steam. Following the stream procedure, the herbal paste is reapplied, the client's body is massaged, and the client to rests and drinks at least one cup of tea.
    Type: Grant
    Filed: February 21, 2009
    Date of Patent: September 20, 2011
    Inventor: Alevtina Brady
  • Publication number: 20110223193
    Abstract: Method of selecting and preparing medical devices comprising extracts of plants and natural substances devoid of pharmacologically, immunologically or metabolically active fractions and characterised by a content of substances able to exert beneficial effects on the body, mediated by mechanical or physical effects, which said process comprises: a) removal by conventional processes of any pharmacologically, immunologically or metabolically active fractions from extracts of plants or natural substances; b) biological testing to establish that the extract or substance obtained in a) is devoid of pharmacological, metabolic and immunological effects; c) formulation of the extracts or substances that pass the test conducted at stage b) into suitable medical devices.
    Type: Application
    Filed: November 10, 2009
    Publication date: September 15, 2011
    Applicant: ABOCA S.P.A. SOCIETA ARGRICOLA
    Inventor: Valentino Mercati
  • Publication number: 20110217397
    Abstract: The present invention comprises compositions, methods and cell lines related to controlling insects. An embodiment of a composition comprises a plant essential oil and targets at least one receptor of insects chosen from tyramine receptor, Or83b olfactory receptor, and Or43a olfactory receptor, resulting in a change in the intracellular levels of cAMP, Ca2+, or both in the insects.
    Type: Application
    Filed: February 3, 2011
    Publication date: September 8, 2011
    Applicant: Tyra Tech, Inc.
    Inventor: Essam Enan
  • Patent number: 7976877
    Abstract: The use of i) finely divided knotwood, or ii) an extract, obtained by extracting knotwood with a polar solvent and recovering the extract, as an antioxidative agent. A fraction of the extract may also be used as an antioxidative agent.
    Type: Grant
    Filed: October 21, 2004
    Date of Patent: July 12, 2011
    Assignee: Oy Arbonova Ab
    Inventors: Stefan Willför, Christer Eckerman, Jarl Hemming, Bjarne Holmbom, Suvi Pietarinen, Anna Sundberg
  • Patent number: 7976879
    Abstract: A product and method for administering daily micronutrient requirements (DMRs) comprising vitamins, minerals and essential fatty acids targeted to reduce appetite and/or the risks associated with aging and associated cognitive impairment. The DMRs are administered to individuals via food products. In an embodiment of the present invention, the DMRs are offered in the form of a health bar, smoothie, or drink. The DMRs may be incorporated into other forms without departing from the scope of the present invention. By way of illustration and not as a limitation, the constituents may be incorporated into a fruit or yogurt “smoothie,” a frozen desert such as an ice cream or sorbet, and a beverage.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: July 12, 2011
    Inventor: Michael F. Roizen
  • Publication number: 20110123467
    Abstract: Topical skin care compositions are provided for the improvement of the appearance of the skin, namely of the skin comprising the face, surrounding the eyes, mouth, and hands, as well as the skin of the body. The skin care compositions include synergistic combinations of active peptide ingredients that are specially formulated to enhance the natural appearance of the face, hands, and/or body. Specifically, the synergistic skin care compositions may be applied to one or more of the skin surrounding the eyes, mouth, nose, forehead, ears, neck, hands, feed, and overall body to give the skin thereof a cleaner, smoother and more wrinkle free appearance.
    Type: Application
    Filed: August 2, 2010
    Publication date: May 26, 2011
    Applicant: Peter Thomas Roth Labs, LLC
    Inventor: PETER T. ROTH
  • Publication number: 20110097396
    Abstract: A cosmetic capsule which can be topically applied and rubbed in and comprises a casing material and a filling material enclosed by the casing material. The casing material is composed of an emulsion which comprises one or more waxes that are solid above 25° C. and the filling material comprising a preparation which has an abrasive effect and comprises one or more abrasive peeling agents which are present in an oil or lipid mixture, a surfactant-containing preparation or an emulsion.
    Type: Application
    Filed: September 12, 2007
    Publication date: April 28, 2011
    Inventors: Svea Wischhoefer, Nils Hoffmann, Silke Weyland, Jessica Schaefer
  • Publication number: 20110091587
    Abstract: Provided are methods and compositions that enhance Nrf2 (SKN-1) activation of phase II detoxification or antioxidant enzyme transcription, comprising plant extracts (e.g., willow extracts) or active fractions thereof, as well as methods for identifying additional compounds that increase the Nrf2-regulation of those enzymes.
    Type: Application
    Filed: September 11, 2008
    Publication date: April 21, 2011
    Applicants: JOSLIN DIABETES CENTER, INC., SUNSTAR INC.
    Inventors: T. Keith Blackwell, Motonobu Matsumoto, Taketoshi Makino, Masashi Goto, Atsushi Ishikado, Mariko Maeda, Satoe Azechi
  • Patent number: 7927635
    Abstract: The invention provides compositions and methods for inhibiting nematode damage to plants. The compositions comprise acid extracts or alcohol extracts from jugloneproducing members of the Juglandaceae. The methods comprise applying the compositions of the invention to soil contacting roots of nematode-susceptible plants.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: April 19, 2011
    Assignee: Redox Chemicals, Inc.
    Inventor: Darin J. Moon
  • Publication number: 20110033556
    Abstract: A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating Hepatitis C, a drug of treating acquired immune deficiency syndrome (AIDS), a drug of treating Tuberculosis, a drug of treat Fibrosis, a drug of treating hydrothorax, a drug of easing pain, a drug of stopping diarrhea, a drug of arresting coughing, a drug of reducing inflammation, and a drug of increasing urine.
    Type: Application
    Filed: June 4, 2010
    Publication date: February 10, 2011
    Inventors: Zheming Jin, Xitian Zhang
  • Publication number: 20110002966
    Abstract: A vaginal suppository system contains a formulation comprising active and inactive ingredients, which active ingredients may be nutraceuticals, herbs, vitamins, minerals and other bioactive agents. In an embodiment, the active ingredients comprise Oak gall, true unicorn root, bitter orange peel, tropical almond, heartsease, and zinc oxide. The formulation may be contained in a soluble encapsulation or a suspension for administration of the formulation in a vagina. A method of preparing a vaginal suppository system and a method of treating a vagina with a formulation comprising active and inactive ingredients are also disclosed.
    Type: Application
    Filed: June 24, 2010
    Publication date: January 6, 2011
    Inventors: Alex Lovett, Marge Siebert
  • Publication number: 20100316744
    Abstract: The present invention relates to plant sprout-based stable oil-in-water emulsions wherein the monacyl- and diacylglycerol content is at least 20% by weight, the free fatty acid content is not more than 10% by weight and comprise an aqueous homogenate of sprouted oily seeds of which the own enzymes and emulsifying substances are capable to form the emulsion. Furthermore, the invention also relates to the preparation of said emulsions as well as to various applications thereof.
    Type: Application
    Filed: June 17, 2008
    Publication date: December 16, 2010
    Inventor: Ferenc Foglein
  • Publication number: 20100316743
    Abstract: The present invention relates to the use of an active substance that promotes the inhibition of the formation of AGEs, for preparing a composition to prevent and/or combat the reduction in elastic and plastic properties of tissues, and in particular of the skin, for inhibiting the formation of AGEs, or for preventing and/or combating glycation of proteins in the skin. The invention also relates to a method of screening such active substances.
    Type: Application
    Filed: July 9, 2008
    Publication date: December 16, 2010
    Applicant: BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S.
    Inventors: Nabil Abdul-Malak, Cecile Altobelli, Eric Perrier
  • Publication number: 20100255127
    Abstract: Disclosed is a safe substance which can inhibit the activity of aromatase (an enzyme capable of converting androgen into estrogen) to thereby effectively treat and/or prevent a sex hormone-dependent disease such as breast cancer occurring in a female person after menopause, as well as a climacteric disorder in a male person and metabolic syndrome caused by the accumulation of a visceral fat. Specifically disclosed is a therapeutic and/or prophylactic agent for a sex hormone-dependent disease, which is characterized by comprising at least one herbal extract selected from the group consisting of “Kokeiten” (golden root), prunella spike, sweet hydrangea leaf, milk thistle, a jasmine tea, “Bokusoku” (a bark of Quercus acutissima or a closely related plant thereof), “Tencha” (sweet tea), “Karensou” (Eclipta prostrata), “Youbaihi” (a bark of Myrica rubra Sie b. et Zucc.), French maritime pine, betel palm, asparagus, “Rouro” (a root of Rhaponticum unifloru m DC.
    Type: Application
    Filed: November 20, 2008
    Publication date: October 7, 2010
    Applicant: KRACIE PHARMA, LTD.
    Inventors: Hisayoshi Norimoto, Yasuo Morimoto